Pandeflu Capsule

About Pandeflu 75 mg Capsule

Pandeflu 75 mg capsule is a medicine made by Advanced Chemical Industries PLC. It is also used to help prevent influenza in adults and adolescents who have been in close contact with someone diagnosed with flu.

There are 11 brands of Oseltamivir listed in Bangladesh. The lowest listed price is Flutavir 75 mg Capsule at ৳ 150.00 per unit.

What is Pandeflu 75 mg Capsule?

Pandeflu comes as a capsule with 75 mg of Oseltamivir, from Advanced Chemical Industries PLC. It works by blocking a viral enzyme needed for the influenza virus to spread. It is used to treat influenza in adults and children over one year of age when the virus is circulating in the community, and to prevent influenza in adults and adolescents who have been in contact with someone diagnosed with flu. Use it only as your doctor directs.

Uses of Pandeflu

It is also used to help prevent influenza in adults and adolescents who have been in close contact with someone diagnosed with flu. Pandeflu is used to treat influenza in adults and in children over one year of age when the influenza virus is circulating in the community. It is not effective against illnesses caused by agents other than influenza viruses types A and B. Ask your doctor whether it is right for your condition.

How to use Pandeflu

The dose, how often to take it and how long to continue are decided by the doctor. Swallow the capsule whole with water. Pandeflu is taken by mouth. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.

Side effects of Pandeflu

Less common side effects reported include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, fever and peritonsillar abscess. The most commonly reported side effects are nausea and vomiting. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Pandeflu is not suitable for people with a known allergy to any of its ingredients. It is not known whether Oseltamivir passes into breast milk, so breastfeeding mothers should use it only when the doctor decides the benefit outweighs the risk. There is not enough human information to judge the risk during pregnancy, so it should be used in pregnancy only if the doctor considers it necessary. Ask your doctor first if any of these apply to you.

Frequently asked questions

Why is Pandeflu prescribed?

It is also used to help prevent influenza in adults and adolescents who have been in close contact with someone diagnosed with flu. Pandeflu is used to treat influenza in adults and in children over one year of age when the influenza virus is circulating in the community.

How do I use Pandeflu correctly?

The dose, how often to take it and how long to continue are decided by the doctor. Swallow the capsule whole with water.

What are the side effects of Pandeflu?

Less common side effects reported include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, fever and peritonsillar abscess. The most commonly reported side effects are nausea and vomiting.

Can I use Pandeflu in pregnancy or while breastfeeding?

Pandeflu is not suitable for people with a known allergy to any of its ingredients. It is not known whether Oseltamivir passes into breast milk, so breastfeeding mothers should use it only when the doctor decides the benefit outweighs the risk.

Indications

Oseltamivir is indicated for prevention of flu (influenza) in adults and adolescents aged 13 years and over who have been in contact with someone diagnosed with flu; treatment of flu (influenza) in adults and in children over one year of age when the influenza virus is circulating in the community

Pharmacology

Oseltamivir is a prodrug of oseltamivir carboxylate. Oseltamivir carboxylate inhibits neuraminidase (sialidase), a viral surface enzyme which is responsible for the replication and infectivity of influenza virus A and B, thereby preventing the release of viruses from infected cells.

Dosage & Administration

Oseltamivir Phosphate may be taken with or without food. However, when taken with food, tolerability may be enhanced in some patients.

Standard oral dose for the treatment of influenza:
  • Adults and Adolescents: The recommended oral dose of Oseltamivir for treatment of influenza in adults and adolescents 13 years and older is 75 mg twice daily for 5 days. Treatment should begin within 2 days of onset of symptoms of influenza.
  • Pediatric patients: The safety and efficacy of Oseltamivir for prophylaxis of influenza in pediatric patients younger than 13 years of age have not been established.
Recommended oral dose for the treatment of influenza:
  • For prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual: 75 mg once daily for at least 7 days. Therapy should begin within 2 days of exposure.
  • For prophylaxis during a community outbreak of influenza: 75 mg once daily. Safety and efficacy have been demonstrated for up to 6 weeks. The duration of protection lasts for as long as dosing is continued.

Interaction

Information derived from pharmacology and pharmacokinetic studies of Oseltamivir suggests that clinically significant drug interactions are unlikely. Co-administration with amoxicillin does not alter plasma levels of either compound.

Contraindications

Oseltamivir is contraindicated in patients with known hypersensitivity to any of the components of the product.

Side Effects

The most frequently reported adverse events are nausea and vomiting. These events generally of mild to moderate degree and usually are occurred on the first 2 days of administration. Additional adverse events occurring in <1% of patients receiving Oseltamivir for treatment include unstable angina, anemia, pseudomembranous colitis, humerus fracture, pneumonia, pyrexia, and peritonsillar abscess.

Pregnancy & Lactation

Pregnancy Category C: There are insufficient human data upon which to base an evaluation of risk of Oseltamivir Phosphate to the pregnant woman or developing fetus.

Nursing Mothers: It is not known whether oseltamivir or oseltamivir carboxylate is excreted in human milk. Oseltamivir Phosphate should, therefore, be used only if the potential benefit for the lactating mother justifies the potential risk to the breast-fed infant.

Precautions & Warnings

There is no evidence for efficacy of Oseltamivir Phosphate in any illness caused by agents other than influenza viruses Types A and B. Efficacy of Oseltamivir Phosphate in patients who begin treatment after 40 hours of symptoms has not been established.

Overdose Effects

At present there has been no experience of over dose. Single dose of up to 1000 mg of Oseltamivir have been associated with nausea and/or vomiting.

Storage Conditions

Store at 25°C. Reconstituted susp: Store between 2-8°C for up to 17 days or at 25°C for up to 10 days. Do not freeze.

Alternative brands of Oseltamivir

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.